You are here: Industry Insights > patent

News List

entrinsic bioscience Secures U.S. Patent Grant for Breakthrough Respiratory Disease Program prnewswire
October 16, 2020
entrinsic bioscience (EBS), a company pioneering a next generation protein modulation technology, announced that it has been granted U.S. Patent No. (USPN) 10,758,507 ('507 patent) for novel therapeutic formulations in the treatment of a range of ...
Catalyst Announces Issuance of U.S. Patent for Firdapse americanpharmaceuticalreview
October 10, 2020
Catalyst Pharmaceuticals announced the United States Patent and Trademark Office (USPTO) has issued a new U.S. patent to Catalyst Pharmaceuticals for Firdapse® (amifampridine), U.S. Patent No. 10,793,893, Methods of Administering 3,4-Diaminopyridine ...
BeyondSpring Files for Patent Protection for Viral Infections Treatment americanpharmaceuticalreview
March 16, 2020
BeyondSpring announced the submission of a provisional U.S. patent application for its pipeline asset BPI-002, for methods of treating viral infections, including COVID-19 ...
INSERM leads in patent applications, reports European Patent Office europeanpharmaceuticalreview
March 13, 2020
According to the European Patent Office (EPO), in 2019 the number of patents filed in the pharmaceutical and biotechnology sectors rose for a third consecutive year.
WPD New Discovery for Cancer Targeting Drugs Granted Patent americanpharmaceuticalreview
January 14, 2020
WPD Pharmaceuticals announced Wake Forest University received a patent from the United States Patent and Trademark Office (USPTO) for patent 105019210 (issued under application number 16/262,195v) licensed to WPD.
Australia grants Patent to Krystal Biotech biospectrumasia
October 08, 2019
This patent covers pharmaceutical compositions comprising KB103, as well as to medical uses thereof, e.g., in the treatment of wounds, disorders, or diseases of the skin, particularly those found in epidermolysis bullosa patients.
Emmaus Granted European Patent for L-glutamine to Treat Diverticulosis americanpharmaceuticalreview
September 04, 2019
Emmaus Life Sciences has announced the allowance of patent application number 12860587.0, directed to the treatment of diverticulosis, by the European Patent Office.
Australia's Propanc Biopharma gets US Patent biospectrumasia
August 25, 2019
Propanc Biopharma Receives Granted US Patent Covering Additional Composition Claims for PRP.
Propanc Biopharma Granted US Patent Covering Additional Composition Claims for PRP americanpharmaceuticalreview
August 23, 2019
Propanc Biopharma, Inc. has received a granted US patent from the United States Patent and Trademark Office (USPTO) covering composition of matter claims involving trypsinogen and chymotrypsinogen.
Perrigo Announces Patent Litigation Settlement for the Generic Version of Nascobal® Nasal Spray americanpharmaceuticalreview
August 23, 2019
Perrigo Company has settled its Hatch-Waxman litigation relating to Nascobal® (Cyanocobalamin) Nasal Spray brought by Endo Pharmaceuticals Inc. Terms of the settlement are confidential.

Previous page 1 2 3 4 5 6 Next page